Primary Localized Gastrointestinal Stromal Tumors: Medication Adherence and Prognosis According to Gender.

Adherence was poorer in male than in female patients, which might explain the worse prognoses of the former among patients who received adjuvant treatment with imatinib. The gender difference in the degree of adherence should be considered in postoperative pharmacotherapy for patients with primary localized GISTs.